Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
EXCELINDUS.NS Stock Summary
Top 10 Correlated ETFs
EXCELINDUS.NS
In the News
EXCELINDUS.NS Financial details
Company Rating
Strong Buy
Market Cap
9.44B
Income
110.15M
Revenue
8.19B
Book val./share
-
Cash/share
-
Dividend
11.25
Dividend %
1.21%
Employees
1.02K
Optionable
No
Shortable
Yes
Earnings
14 May 2024
P/E
43.29
Forward P/E
-
PEG
-4.65
P/S
1.36
P/B
0.84
P/C
-
P/FCF
-
Quick Ratio
2.73
Current Ratio
3.28
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
8.76
EPS next Y
-
EPS next Q
-
EPS this Y
-50.41%
EPS next Y
-
EPS next 5Y
1595.21%
EPS last 5Y
-12.23%
Revenue last 5Y
5.8%
Revenue Q/Q
-8.97%
EPS Q/Q
50%
-
-
-
-
SMA20
-13.08%
SMA50
-21.4%
SMA100
-14.6%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
4%
ROC
0.02%
Gross Margin
40%
Oper. Margin
3%
Profit Margin
3%
Payout
-
Shs Outstand
12.57M
Shs Float
5.67M
-
-
-
-
Target Price
-
52W Range
710.35-1017.5
52W High
-30.42%
52W Low
-0.34%
RSI
30
Rel Volume
2.68
Avg Volume
18.32K
Volume
49.06K
Perf Week
-3.27%
Perf Month
-15.65%
Perf Quarter
-18.14%
Perf Half Y
-19.74%
-
-
-
-
Beta
0.722
-
-
Volatility
12.96%, 50.58%
Prev Close
-2.1%
Price
707.6
Change
-5.02%
EXCELINDUS.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 654.04 | 556.51 | 596.2 | 932.6 | 866.95 | |
Net income per share | 122.07 | 76.43 | 56.55 | 128.24 | 63.59 | |
Operating cash flow per share | 107.52 | 87.65 | 72.28 | 86.66 | 99.71 | |
Free cash flow per share | 70.52 | 35.34 | 34.32 | 27.87 | 73.74 | |
Cash per share | 64.68 | 28.56 | 54.63 | 61.33 | 119.2 | |
Book value per share | 556.5 | 557.59 | 677.4 | 914.31 | 987.81 | |
Tangible book value per share | 556.08 | 541.98 | 647.14 | 899.04 | 972.57 | |
Share holders equity per share | 556.5 | 557.59 | 677.4 | 914.31 | 987.81 | |
Interest debt per share | 7.17 | 20.96 | 8.56 | 7.09 | 3.85 | |
Market cap | 15.11B | 5.62B | 10.6B | 17.24B | 9.99B | |
Enterprise value | 15.14B | 5.65B | 10.27B | 17.01B | 9.99B | |
P/E ratio | 9.84 | 5.85 | 14.92 | 10.69 | 12.5 | |
Price to sales ratio | 1.84 | 0.8 | 1.41 | 1.47 | 0.92 | |
POCF ratio | 11.18 | 5.1 | 11.67 | 15.82 | 7.97 | |
PFCF ratio | 17.04 | 12.64 | 24.58 | 49.19 | 10.78 | |
P/B Ratio | 2.16 | 0.8 | 1.25 | 1.5 | 0.8 | |
PTB ratio | 2.16 | 0.8 | 1.25 | 1.5 | 0.8 | |
EV to sales | 1.84 | 0.81 | 1.37 | 1.45 | 0.92 | |
Enterprise value over EBITDA | 5.93 | 4.03 | 7.89 | 6.93 | 7.23 | |
EV to operating cash flow | 11.2 | 5.13 | 11.3 | 15.61 | 7.97 | |
EV to free cash flow | 17.08 | 12.71 | 23.8 | 48.54 | 10.77 | |
Earnings yield | 0.1 | 0.17 | 0.07 | 0.09 | 0.08 | |
Free cash flow yield | 0.06 | 0.08 | 0.04 | 0.02 | 0.09 | |
Debt to equity | 0.01 | 0.03 | 0.01 | 0.01 | 0 | |
Debt to assets | 0.01 | 0.03 | 0.01 | 0 | 0 | |
Net debt to EBITDA | 0.01 | 0.02 | -0.26 | -0.09 | -0.01 | |
Current ratio | 2.8 | 1.89 | 2.09 | 2.36 | 3.63 | |
Interest coverage | 119.43 | 48.42 | 44.11 | 134.05 | 46.28 | |
Income quality | 0.58 | 0.96 | 0.9 | 0.51 | 1.19 | |
Dividend Yield | 0.01 | 0.08 | 0 | 0.01 | 0.03 | |
Payout ratio | 0.12 | 0.45 | 0 | 0.09 | 0.35 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | |
Research and developement to revenue | 0.01 | 0.01 | 0 | 0 | 0.01 | |
Intangibles to total assets | 0 | 0.02 | 0.02 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.34 | -0.6 | -0.53 | -0.68 | -0.26 | |
Capex to revenue | -0.06 | -0.09 | -0.06 | -0.06 | -0.03 | |
Capex to depreciation | -2.57 | -2.89 | -1.76 | -2.41 | -1.04 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.24K | 979.22 | 928.38 | 1.62K | 1.19K | |
ROIC | 0.22 | 0.12 | 0.08 | 0.13 | 0.06 | |
Return on tangible assets | 0.17 | 0.1 | 0.07 | 0.11 | 0.05 | |
Graham Net | 25.29 | -29.77 | -20.09 | -0.38 | 66.06 | |
Working capital | 2.1B | 1.32B | 1.72B | 2.76B | 3.24B | |
Tangible asset value | 6.99B | 6.81B | 8.32B | 11.3B | 12.23B | |
Net current asset value | 1.11B | 437.57M | 695.86M | 1.41B | 1.97B | |
Invested capital | 0.01 | 0.03 | 0.01 | 0.01 | 0 | |
Average receivables | 1.56B | 1.71B | 1.7B | 2.06B | 1.97B | |
Average payables | 935.82M | 1.02B | 1.14B | 1.52B | 1.44B | |
Average inventory | 622.96M | 732.33M | 733.45M | 1.17B | 1.48B | |
Days sales outstanding | 78.27 | 86.46 | 85.19 | 73.52 | 52.83 | |
Days payables outstanding | 91.34 | 100.29 | 121.6 | 96.1 | 61.83 | |
Days of inventory on hand | 62.91 | 74.3 | 68.18 | 87.99 | 76.06 | |
Receivables turnover | 4.66 | 4.22 | 4.28 | 4.96 | 6.91 | |
Payables turnover | 4 | 3.64 | 3 | 3.8 | 5.9 | |
Inventory turnover | 5.8 | 4.91 | 5.35 | 4.15 | 4.8 | |
ROE | 0.22 | 0.14 | 0.08 | 0.14 | 0.06 | |
Capex per share | -36.99 | -52.31 | -37.96 | -58.78 | -25.98 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 177.37 | 179.86 | 170.46 | 157.55 | 143.52 | |
Net income per share | 14.86 | 0.54 | 4.67 | 1.42 | 2.13 | |
Operating cash flow per share | 12.49 | 12.47 | 14.07 | 58.23 | 12.5 | |
Free cash flow per share | 12.49 | 12.47 | 14.07 | 47.18 | 12.5 | |
Cash per share | 141.24 | 119.2 | 114.04 | 167.2 | 0 | |
Book value per share | 963.46 | 987.85 | 987.81 | 1.11K | 0 | |
Tangible book value per share | 0 | 972.61 | 0 | 1.09K | 0 | |
Share holders equity per share | 963.46 | 987.85 | 987.81 | 1.11K | 0 | |
Interest debt per share | 0.29 | 2.43 | 0.46 | 1.64 | 0.59 | |
Market cap | 14.36B | 9.99B | 12.39B | 11.1B | 11.95B | |
Enterprise value | 16.13B | 9.98B | 13.82B | 11.08B | 11.95B | |
P/E ratio | 19.21 | 368.13 | 52.72 | 155.48 | 111.65 | |
Price to sales ratio | 6.44 | 4.42 | 5.78 | 5.61 | 6.63 | |
POCF ratio | 91.44 | 63.76 | 70.04 | 15.17 | 76.09 | |
PFCF ratio | 91.44 | 63.76 | 70.04 | 18.72 | 76.09 | |
P/B Ratio | 1.19 | 0.8 | 1 | 0.8 | 0 | |
PTB ratio | 1.19 | 0.8 | 1 | 0.8 | 0 | |
EV to sales | 7.24 | 4.42 | 6.45 | 5.6 | 6.63 | |
Enterprise value over EBITDA | 53.95 | 82.41 | 80.68 | 110.87 | 720.28 | |
EV to operating cash flow | 102.74 | 63.7 | 78.15 | 15.14 | 76.09 | |
EV to free cash flow | 102.74 | 63.7 | 78.15 | 18.68 | 76.09 | |
Earnings yield | 0.01 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0.01 | 0.02 | 0.01 | 0.05 | 0.01 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 5.94 | -0.07 | 8.37 | -0.19 | 0 | |
Current ratio | 0 | 3.63 | 0 | 3.28 | 0 | |
Interest coverage | 60.97 | 11.14 | -1.87 | 8.54 | -8.32 | |
Income quality | 0.84 | 7.25 | 3.01 | 41 | 5.87 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
Payout ratio | 0 | 0 | 0 | 7.91 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.03 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.01 | 0 | 0.01 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | -0.19 | 0 | |
Capex to revenue | 0 | 0 | 0 | -0.07 | 0 | |
Capex to depreciation | 0 | 0 | 0 | -0.89 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 567.63 | 109.55 | 322.31 | 187.94 | 0 | |
ROIC | 0.02 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 141.24 | 66.06 | 114.04 | 62.66 | 0 | |
Working capital | 1.78B | 3.24B | 1.43B | 3.16B | 0 | |
Tangible asset value | 0 | 12.23B | 0 | 13.71B | 0 | |
Net current asset value | 1.78B | 1.97B | 1.43B | 1.64B | 0 | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 1.02B | 788.68M | 788.68M | 840.12M | 840.12M | |
Average payables | 836.46M | 534.25M | 534.25M | 602.1M | 602.1M | |
Average inventory | 611.11M | 657.21M | 657.21M | 333.88M | 333.88M | |
Days sales outstanding | 0 | 62.79 | 0 | 76.36 | 0 | |
Days payables outstanding | 0 | 68.7 | 0 | 86.61 | 0 | |
Days of inventory on hand | 0 | 84.52 | 0 | 48.03 | 0 | |
Receivables turnover | 0 | 1.43 | 0 | 1.18 | 0 | |
Payables turnover | 0 | 1.31 | 0 | 1.04 | 0 | |
Inventory turnover | 0 | 1.06 | 0 | 1.87 | 0 | |
ROE | 0.02 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | -11.04 | 0 |
EXCELINDUS.NS Frequently Asked Questions
What is Excel Industries Limited stock symbol ?
Excel Industries Limited is a IN stock and trading under the symbol EXCELINDUS.NS
What is Excel Industries Limited stock quote today ?
Excel Industries Limited stock price is $707.6 today.
Is Excel Industries Limited stock public?
Yes, Excel Industries Limited is a publicly traded company.